BioHemp International Provides Update on Current Status and its CBD Business Model
24 oct. 2019 12h02 HE
|
BioHemp International
NEW YORK, Oct. 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – BioHemp International, Inc. (OTC: BKIT), (“Company”), a Company focused on consolidating distributors in the CBD industry, provides...
BioHemp International, Inc. (OTC: BKIT) Acts in Response to SEC and OTC Trading Suspension
09 août 2019 10h56 HE
|
BioHemp International
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – As previously disclosed on July 26th, 2019, the Securities and Exchange Commission ("Commission") announced the temporary suspension,...
BioHemp International (OTC: BKIT) Clarifies Recent 8-K - No Material Change in Share Structure
15 juil. 2019 10h00 HE
|
BioHemp International
NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – BioHemp International, Inc. (OTC: BKIT) (the "Company”) clarifies that in the 8-K filed on July 12th, 2019, the 25 million shares issued...
Daniel Blum, CEO at BioHemp International (OTC: BKIT), discusses new position, CBD opportunities, and long-term company goals with Cannabis Hemp Wire
10 juil. 2019 08h30 HE
|
BioHemp International
NEW YORK, July 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Cannabis Hemp Wire’s David Hempstein interviewed new BioHemp International (OTC: BKIT) CEO, Daniel Blum earlier this week to discuss new...
BioHemp International, Inc. (OTC: BKIT) Announces Deal to Private Label Water From American Premium Water Corporation (OTC: HIPH)
08 juil. 2019 08h30 HE
|
BioHemp International
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – BioHemp International, Inc. (OTC: BKIT), (“Company”), a Company focused on consolidating the CBD industry, announces that it has entered...
Ludlow Research Initiates Coverage on BioHemp International (BKIT) Based on CBD Distribution Business Model And Assigns A Short Term 'Speculative' Price Target Per Share of $2.50 -$3.50
02 juil. 2019 09h15 HE
|
BioHemp International
NEW YORK, July 02, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- BioHemp International, Inc. (OTC: BKIT), (“Company”) announces a research opinion on the company is now available for download. ...
BioHemp International, Inc (OTC: BKIT) Appoints Ryan Fishoff as Lead Advisor to Company to Assist With CBD Distribution Consolidation Focus
24 juin 2019 11h23 HE
|
BioHemp International
NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – BioHemp International, Inc. (OTC: BKIT), (“Company”) announces that it has appointed American Premium Water Corporation (OTC: HIPH)...
Blake Insomnia Therapeutics, Inc Completes Name Change to BioHemp International, Inc (OTC: BKIT) and Appoints Daniel Blum as New CEO to Spearhead CBD Distribution Consolidation Focus
18 juin 2019 12h08 HE
|
BioHemp International
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – The Company, previously Blake Insomnia Therapeutics Inc, confirms its successful name change to BioHemp International, Inc. (OTC: BKIT)...
Blake Insomnia Therapeutics, Inc. (OTC:BKIT) Announces Change in Business Strategy and name change submission to BioHemp International to Focus on a Rollup Strategy in the CBD Market
15 mai 2019 08h00 HE
|
Blake Insomnia Therapeutics, Inc.
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics, Inc (OTC: BKIT, “The Company”) announces that it is rebranding and changing its business model to take advantage of the huge...
Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing
25 août 2017 09h30 HE
|
Blake Insomnia Therapeutics, Inc.
NEW YORK, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT), a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is...